The body weight reduction was 2.3 kg with SGLT2 inhibitors as add-on treatment in DM compared with placebo (N = 1000, MD −2.30 kg, 95%CI [−3.09 to −1.50], P < .00001 (Fig. 5). The gene discussed is SLC5A2; the disease is diabetes mellitus.